Gene · 4646
Papers1,778
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,778
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Revealing Different Pathways for Influenza A Virus To Reach Microtubules after Endocytosis by Quantum Dot-Based Single-Virus Tracking. | ACS Nano | 2024 | 39143650 | PubTator, text mining | PubMed |
| Motor domain phosphorylation increases nucleotide exchange and turns MYO6 into a faster and stronger motor. | Nat Commun | 2024 | 39112473 | PubTator, text mining | PubMed |
| Circ_0000395 promotes cell growth, metastasis and oxaliplatin resistance by regulating miR-153-5p/MYO6 in colorectal cancer. | Pathol Res Pract | 2024 | 39038387 | PubTator, text mining | PubMed |
| Targeted Next-Generation Sequencing Analysis Reveals a Novel Genetic Variant in MYO6 Gene in an Indian Family with Postlingual Nonsyndromic Hearing Loss. | Genet Test Mol Biomarkers | 2024 | 39019031 | PubTator, text mining | PubMed |
| The genomic landscape of Ménière's disease: a path to endolymphatic hydrops. | BMC Genomics | 2024 | 38943082 | PubTator, text mining | PubMed |
| Editorial: Unconventional myosins in motile and contractile functions: fifty years on the stage. | Front Physiol | 2024 | 38933364 | PubTator, text mining | PubMed |
| Integrated Analysis of Genomic and Genome-Wide Association Studies Identified Candidate Genes for Nutrigenetic Studies in Flavonoids and Vascular Health: Path to Precision Nutrition for (Poly)phenols. | Nutrients | 2024 | 38732608 | PubTator, text mining | PubMed |
| The Suppression of the Epithelial to Mesenchymal Transition in Prostate Cancer through the Targeting of MYO6 Using MiR-145-5p. | Int J Mol Sci | 2024 | 38673886 | PubTator, text mining | PubMed |
| A weak coupling mechanism for the early steps of the recovery stroke of myosin VI: A free energy simulation and string method analysis. | PLoS Comput Biol | 2024 | 38662764 | PubTator, text mining | PubMed |
| The two C. elegans class VI myosins, SPE-15/HUM-3 and HUM-8, share similar motor properties, but have distinct developmental and tissue expression patterns. | Front Physiol | 2024 | 38660538 | PubTator, text mining | PubMed |
| Cooperation of Various Cytoskeletal Components Orchestrates Intercellular Spread of Mitochondria between B-Lymphoma Cells through Tunnelling Nanotubes. | Cells | 2024 | 38607046 | PubTator, text mining | PubMed |
| Pathophysiology of human hearing loss associated with variants in myosins. | Front Physiol | 2024 | 38562617 | PubTator, text mining | PubMed |
| Molecular Mechanism of Autophagosome-Lysosome Fusion in Mammalian Cells. | Cells | 2024 | 38534345 | PubTator, text mining | PubMed |
| Mutational spectrum in patients with dominant non-syndromic hearing loss in Austria. | Eur Arch Otorhinolaryngol | 2024 | 38400873 | PubTator, text mining | PubMed |
| Autoinhibition and activation of myosin VI revealed by its cryo-EM structure. | Nat Commun | 2024 | 38331992 | PubTator, text mining | PubMed |
| A Novel Deleterious MYO15A Gene Mutation Causes Nonsyndromic Hearing Loss. | Iran J Otorhinolaryngol | 2024 | 38259694 | PubTator, text mining | PubMed |
| Location, location, location: Protein kinase nanoclustering for optimised signalling output. | Elife | 2024 | 38206309 | PubTator, text mining | PubMed |
| Integrative single-cell characterization of a frugivorous and an insectivorous bat kidney and pancreas. | Nat Commun | 2024 | 38195585 | PubTator, text mining | PubMed |
| A revised nomenclature for the lemur family of protein kinases. | Commun Biol | 2024 | 38191649 | PubTator, text mining | PubMed |
| Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells. | Cancer Cell Int | 2024 | 38184562 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4646/papers?page=4